Decibel Therapeutics Inc

NASDAQ:DBTX  
2.30
-0.02 (-0.86%)
Earnings Announcements

Decibel Therapeutics Reports Fourth Quarter And Full Year 2021 Financial Results And Corporate Update

Published: 03/18/2022 11:20 GMT
Decibel Therapeutics Inc (DBTX) - Decibel Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Update.
Decibel Therapeutics - Believes That Existing Cash, Cash Equivalents & Available-for-sale Securities Will Fund Pipeline Programs & Operating Expenses Into 2024.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.57

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.58

More details on our Analysts Page.